![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » U.S. Patent Office Issues Notice of Allowance to Dermisonics
U.S. Patent Office Issues Notice of Allowance to Dermisonics
May 5, 2005
Dermisonics, a medical device company with its focus on the development of an ultrasonically assisted transdermal drug-delivery technology, announced that the U.S. Patent and Trademark Office has issued a notice of allowance for the approval of the most substantial patent claims for the Medi-Cap, a groundbreaking transdermal drug-delivery device.
MENAFN (http://menafn.com/qn_news_story.asp?StoryId=CqNHiWbKbmti0yJq4ndC)
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
21Oct